SB 209

This bill allows an authorized individual to acquire and maintain a supply of

epinephrine auto-injectors and provide or administer an epinephrine auto-injector

to an individual that the authorized individual believes is experiencing anaphylaxis

regardless of whether that individual has a prescription for an epinephrine

auto-injector or has been diagnosed with an allergy. Under the bill, an authorized

individual is one who operates or participates in a business, activity, or event at

which allergens capable of causing anaphylaxis may be present.

Under current law, certain prescribers are allowed to prescribe epinephrine

auto-injectors in the name of authorized entities. Authorized entities, currently, are

entities or organizations, other than schools, that operate a business, activity, or

event at which allergens capable of causing anaphylaxis may be present. Current

law allows an authorized entity to acquire and maintain a supply of epinephrine

auto-injectors and requires those that do to comply with certain storage

requirements for the auto-injectors. An employee or agent of an authorized entity,

or other individual, who has completed the required training may use an epinephrine

auto-injector to provide or administer to an individual that he or she believes is

experiencing anaphylaxis. Under current law the authorized entity, its employees

or agents, and other individuals are not liable for injuries resulting from

administering or failing to administer an epinephrine auto-injector. This bill allows

prescribers to prescribe epinephrine auto-injectors to authorized individuals, allows

authorized individuals to acquire and maintain a supply of epinephrine

auto-injectors, subjects authorized individuals to the same storage and training

requirements as authorized entities, and provides the same liability exemptions to

authorized individuals as current law provides for authorized entities. Additionally,

the bill expands authorized entities to include entities and organizations that

participate in a business, activity, or event at which allergens capable of causing

anaphylaxis may be present.